Conspectus For the delivery of drugs, different nanosized drug carriers (eg, liposomes, lipid
nanoparticles, and micelles) have been developed in order to treat diseases that afflict …

Encapsulating anticancer drugs in nanoparticles has proven to be an effective mechanism to
alter the pharmacokinetic and pharmacodynamic profiles of the drugs, leading to clinically …

Peptides are being successfully used in various fields including therapy and drug delivery.
With advancement in nanotechnology and targeted delivery carrier systems, suitable …

Lipid nanoparticles (LNPs) have gained prominence as primary carriers for delivering a
diverse array of therapeutic agents. Biological products have achieved a solid presence in …

Biological membrane-engineered lipid nanoparticles (LNP) have shown enormous potential
as vehicles for drug delivery due to their outstanding biomimetic properties. To make these …

Based on their tunable physicochemical properties and the possibility of producing cell-
specific platforms through surface modification with functional biomolecules, nanoparticles …

Since the recent clinical approval of siRNA-based drugs and COVID-19 mRNA vaccines, the
potential of RNA therapeutics for patient healthcare has become widely accepted. Lipid …

Amphiphilic self-assembling peptides are functional materials, which, depending on the
amino acid sequence, the peptide length, and the physicochemical conditions, form a variety …

Stealth agents are extensively investigated as a means by which to prolong nanostructure
residence time in the bloodstream by avoiding uptake by the reticuloendothelial system …

Nanocarriers can fulfill essential functions in the stabilization and delivery of drugs: they
prevent solubility issues and degradation, reduce side effects and modify the …